Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / United States — National Cancer Institute

United States — Food and Drug Administration & United States — National Cancer Institute

1 shared events · Importance 3 · Last updated Jun 16, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
0
Business
Oryzon Genomics Q1 2026 Results, Drug Progress
United States — National Cancer Institute: The United States — National Cancer Institute is sponsoring trials for iadademstat in various hematologic malignancies and solid tumors under a Cooperative Research and Development Agreement with Oryzon Genomics.
May 14, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and United States — National Cancer Institute interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.